Dr. S MURUGESAN
Professor,
Department of Pharmacy,
Birla Institute of Technology and Science,
Vidhya Vihar, Pilani- 333031.
Rajasthan, India.
Every published article is freely available to read, download and share — immediately upon publication, worldwide.
A multidisciplinary platform for research on cancer epidemiology, molecular oncology, pharmacology, immunotherapy, and biological treatments.
Current issue, accepted articles and archives.
Meet the Editor-in-Chief and the international Editorial Board.
Editorial policies, manuscript preparation and publication guidance.
Professor, Department of Pharmaceutical Chemistry & Analysis, VISTAS, Chennai, India.
Cancer epidemiologyMolecular oncologyCancer immunologyPrecision medicineNanomedicineBiological therapeuticsDrug discoveryClinical and translational oncology
Cancer Research and Biological Therapeutics is a proposed multidisciplinary scientific journal focused on fundamental, translational and clinical cancer research, including mechanisms of carcinogenesis, tumour biology, epidemiology, diagnostics, pharmacology and emerging biological therapies.
Topics include cancer prevention and epidemiology; cellular and molecular oncology; tumour microenvironment; biomarkers; cancer genomics and proteomics; pharmacogenomics; immunotherapy; monoclonal antibodies; cell and gene therapies; drug delivery; nanomedicine; natural-product research; computational oncology; and translational therapeutic evaluation.
Journal title: Cancer Research and Biological Therapeutics
Abbreviation: CRBT (proposed)
ISSN: To be assigned
Publisher: SDN Publishers
Publication frequency: Bi-Monthly
Access model: Open Access
Editorial office email: publish@crbtonline.com
Articles published in the current issue.
Accepted, peer-reviewed articles available before inclusion in an issue.
Articles from previous volumes and issues.
The article is added to the tab that is currently open: Current issue.
Uploaded PDFs are saved in this web browser. To make articles visible to every visitor, list them in the PUBLISHED_ARTICLES section of the page with the PDF placed in an articles folder on your web host.
Professor / Research
Department of Pharmaceutical Chemistry & Analysis
School of Pharmaceutical Sciences
Vels Institute of Science, Technology & Advanced Studies (VISTAS)
Pallavaram, Chennai, Tamil Nadu 600117, India
Associate Professor
Room 416, School of Chemistry and Chemical Engineering
Jiangsu University, China
Professor,
Department of Pharmacy,
Birla Institute of Technology and Science,
Vidhya Vihar, Pilani- 333031.
Rajasthan, India.
Professor of Pharmaceutical Chemistry,
Faculty of Pharmacy,
M.S. Ramaiah University of Applied Sciences,
University House, Gnanagangothri Campus,
New BEL Road, M.S. R Nagar,
Bengaluru-560054, Karnataka, India.
Professor
Center for Computational Biology,
SRM Institute of Science and Technology,
Tiruchirappalli, Tamil Nadu 621105, India
Mobile No.: +91-9629396767
Professor
Department of Pharmaceutical Chemistry
JSS College of Pharmacy
Ooty, Tamilnadu
Professor and Head
Department of Pharmacology
Manipal College of Pharmaceutical Sciences
Manipal
Department of Immunology,
Jiangsu Key Laboratory of Laboratory Medicine,
School of Medicine, Advances in Therapy,
School of Clinical Medicine & Laboratory Medicine,
School of Chemistry and Chemical Engineering,
Jiangsu University, Zhenjiang-212013, P.R. China.
Faculty of Health Sciences,
Villa College,
Boduthakurufaanu
Magu, Malé, Maldives
Vice Rector of Research and Innovation (RIN)
Professor of Bioinformatics
Indonesia International Institute for Life Sciences (i3l)
Associate member of European Virus Bioinformatics Center, Leutragraben 1, 07743 Jena, Germany, Institutional Weblog: http://i3l.ac.id/project/dr-rer-nat-arli-aditya-parikesit/
Personal Weblog: https://www.zotero.org/arli123
University of Warsaw,
Faculty of Biology,
Department of Hydrobiology
Krakowskie Przedmieście
26/28, 00-927 Warszawa, Poland
Original Research Articles · Review Articles · Systematic Reviews and Meta-Analyses · Short Communications · Case Reports (where suitable) · Perspectives · Letters to the Editor.
Submit a clear title page, structured abstract as appropriate, keywords, introduction, methods, results, discussion, conclusion, references, tables, figure legends, and supplementary materials. Report ethical approvals, informed consent, funding, conflicts of interest, author contributions and data availability where applicable.
Use appropriate reporting guidelines such as CONSORT, STROBE, PRISMA, ARRIVE or other relevant standards.
Confirm authorship, originality, permission for reused content, human/animal ethics approvals, figure quality, reference accuracy and declarations.
Reviewers should assess originality, scientific rigor, ethics, reproducibility, statistical methods, reporting transparency and relevance. Declare conflicts of interest and maintain manuscript confidentiality.
Accept · Minor revision · Major revision · Reject
Summary of contribution; major comments; minor comments; confidential comments to editor; recommendation.
Proposed model: independent expert review with editorial oversight. Final review model requires confirmation.
Originality, authorship, conflicts, data transparency, ethical approvals and research misconduct procedures.
Corrections, expressions of concern, retractions and appeals under documented editorial procedures.
Publication ethics, plagiarism screening, AI-use disclosure, clinical trial registration, informed consent, animal welfare, data sharing, image integrity, reviewer confidentiality, copyright, licensing, privacy and complaints.
Illustrative submission flow based on standard scholarly publishing workflows.
Editor-in-Chief: Dr. Panneerselvam Theivendren
Department of Pharmaceutical Chemistry & Analysis
School of Pharmaceutical Sciences
Vels Institute of Science, Technology, & Advanced Studies
Pallavaram, Chennai, Tamil Nadu 600117, India
Editor-in-Chief email: panneerselvam.sps@vistas.ac.in
Editorial office email: publish@crbtonline.com
For editorial enquiries, manuscript assistance, permissions and journal policy questions, use the official contact details once published.